Use access key #2 to skip to page content.
$5.71 -0.19 (-3.22%)
9/4/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar antonioexpo (52.08) Submitted: 8/28/06 4:14 AM : Outperform Start Price: $8.20 EXEL Score: -26.02

The next big biotech

Report this Post Replies: 0 | Reply

Featured Broker Partners